MiniMed Group, Inc. 8-K
Research Summary
AI-generated summary
MiniMed Group Reports Q4 and Fiscal Year 2026 Results
What Happened
- MiniMed Group, Inc. announced its financial results for the fourth quarter and full fiscal year 2026 in a press release dated June 3, 2026. The company furnished that press release to the SEC as Exhibit 99.1 in a Form 8-K filed June 3, 2026.
Key Details
- Filing date: June 3, 2026 (Form 8-K covering Item 2.02 and Item 7.01).
- Press release: Q4 and FY2026 earnings and related information attached as Exhibit 99.1 and incorporated by reference in the Form 8-K.
- Regulation FD note: The furnished press release is disclosed under Regulation FD and is expressly not deemed “filed” for purposes of Section 18 of the Securities Exchange Act.
- Executed by: Chad Spooner, Executive Vice President and Chief Financial Officer, signed the Form 8-K.
Why It Matters
- This filing signals the company has released its latest quarterly and annual earnings information — key inputs for evaluating recent revenue, profitability and financial condition. Investors should review the attached press release (Exhibit 99.1) and any subsequent SEC filings for the specific financial results and management commentary. The Regulation FD statement means the release is furnished for disclosure but is not subject to certain Section 18 liabilities.
Loading document...